|
Market Closed -
Hong Kong S.E.
08:08:21 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 4.735 HKD | -0.42% |
|
-6.05% | -10.15% |
| 10-09 | GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target | MT |
| 09-24 | CStone Pharma CEO Buys HK$2.7 Million of Shares | MT |
| Market Cap | 6.4B 7.54B 961M 860M 794M 718M 1.34B 91.47B 1.36B 9.47B 3.78B 47.87B 3.6B 3.53B 152B | P/E 2026 * |
-13.9x | P/E 2027 * | 1.96x |
|---|---|---|---|---|---|
| Enterprise Value | 5.42B 6.39B 814M 729M 672M 609M 1.14B 77.5B 1.16B 8.02B 3.2B 40.56B 3.05B 2.99B 128B | EV / Sales 2026 * |
12.8x | EV / Sales 2027 * | 0.9x |
| Free-Float |
79.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript: CStone Pharmaceuticals
| 1 day | -0.42% | ||
| 1 week | -6.05% | ||
| Current month | -19.75% | ||
| 1 month | -7.88% | ||
| 3 months | +7.37% | ||
| 6 months | -49.73% | ||
| Current year | -10.15% |
| 1 week | 4.53 |  | 5.22 |
| 1 month | 4.53 | | 5.95 |
| Current year | 4.01 | | 10.41 |
| 1 year | 4.01 | | 10.41 |
| 3 years | 0.8 | | 13.15 |
| 5 years | 0.8 | | 13.15 |
| 10 years | 0.8 | | 19.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 24/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 17/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 31/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 24/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 08/07/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/09/26 | Other | Chief Executive Officer | 291,500 | 0.0182% | ||
| 18/09/26 | Other | Chief Executive Officer | 72,000 | 0.0045% | ||
| 17/09/26 | Other | Chief Executive Officer | 132,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | -6.05% | -24.84% | +140.36% | 965M | |
| +6.63% | +5.13% | +68.86% | +142.83% | 1,148B | |
| +1.53% | +2.84% | +47.48% | +87.17% | 652B | |
| +1.68% | +1.96% | +29.16% | +104.94% | 505B | |
| +0.73% | +2.45% | +54.26% | +66.47% | 384B | |
| +3.83% | -0.62% | +69.01% | +42.51% | 348B | |
| +2.38% | +2.65% | +34.31% | +56.33% | 294B | |
| +2.26% | +0.55% | +3.92% | +27.74% | 264B | |
| +1.97% | +3.01% | +57.91% | +75.06% | 244B | |
| +4.03% | +5.36% | +39.76% | +112.95% | 197B | |
| Average | +2.56% | +0.68% | +37.98% | +85.63% | 403.81B | |
| Weighted average by Cap. | +3.45% | +1.50% | +50.20% | +93.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 498M 63.49M 56.87M 52.47M 47.48M 88.78M 6.05B 90.22M 626M 250M 3.16B 238M 233M 10.02B | 2.63B 3.1B 395M 353M 326M 295M 552M 37.57B 561M 3.89B 1.55B 19.66B 1.48B 1.45B 62.27B |
| Net income | -384M -452M -57.55M -51.55M -47.56M -43.04M -80.47M -5.48B -81.77M -567M -226M -2.87B -216M -211M -9.08B | 1.32B 1.55B 198M 177M 163M 148M 276M 18.83B 281M 1.95B 778M 9.85B 742M 726M 31.21B |
| Net Debt | -978M -1.15B -147M -131M -121M -110M -205M -13.97B -208M -1.45B -577M -7.31B -551M -539M -23.16B | -4.02B -4.74B -604M -541M -499M -451M -844M -57.48B -858M -5.95B -2.37B -30.08B -2.27B -2.22B -95.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | HK$4.735 | -0.42% | 3,955,642 |
| 28/10/26 | HK$4.755 | +4.05% | 5,297,612 |
| 27/10/26 | HK$4.570 | -7.21% | 7,890,500 |
| 26/10/26 | HK$4.925 | +1.13% | 8,386,448 |
| 23/10/26 | HK$4.870 | +3.62% | 5,146,588 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
Select your edition
All financial news and data tailored to specific country editions
